These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22395013)

  • 21. NF1, Neurofibromin and Gene Therapy: Prospects of Next-Generation Therapy.
    Cui XW; Ren JY; Gu YH; Li QF; Wang ZC
    Curr Gene Ther; 2020; 20(2):100-108. PubMed ID: 32767931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent developments in neurofibromatosis type 1.
    Lee MJ; Stephenson DA
    Curr Opin Neurol; 2007 Apr; 20(2):135-41. PubMed ID: 17351482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Genetics of type 1 neurofibromatosis].
    Garavelli L; Donadio A; Sigorini M; Grassi L; Banchini G
    Acta Biomed Ateneo Parmense; 2000; 71(3-4):89-95. PubMed ID: 11424621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [von Recklinghausen's disease and its pathogenesis].
    Sakai A; Suzuki K
    Nihon Rinsho; 1995 Nov; 53(11):2688-90. PubMed ID: 8538027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The genetic and molecular pathogenesis of NF1 and NF2.
    Yohay KH
    Semin Pediatr Neurol; 2006 Mar; 13(1):21-6. PubMed ID: 16818172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Neurofibromatosis type 1 --Recklinghausen's disease; pathogenesis and clinical symptoms].
    Stenzel A; Kostuch M; Wojcierowski J
    Med Wieku Rozwoj; 1999; 3(1):41-6. PubMed ID: 10910637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mice with missense and nonsense NF1 mutations display divergent phenotypes compared with human neurofibromatosis type I.
    Li K; Turner AN; Chen M; Brosius SN; Schoeb TR; Messiaen LM; Bedwell DM; Zinn KR; Anastasaki C; Gutmann DH; Korf BR; Kesterson RA
    Dis Model Mech; 2016 Jul; 9(7):759-67. PubMed ID: 27482814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Anxiety disorders in type 1 neurofibromatosis: A case report].
    Fekih-Romdhane F; Othman S; Sahnoun C; Helayem S; Abbes Z; Bouden A
    Arch Pediatr; 2015 Sep; 22(9):956-60. PubMed ID: 26228808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pigment cell-related manifestations in neurofibromatosis type 1: an overview.
    De Schepper S; Boucneau J; Lambert J; Messiaen L; Naeyaert JM
    Pigment Cell Res; 2005 Feb; 18(1):13-24. PubMed ID: 15649148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mouse models of neurofibromatosis.
    McClatchey AI; Cichowski K
    Biochim Biophys Acta; 2001; 1471(2):M73-80. PubMed ID: 11342186
    [No Abstract]   [Full Text] [Related]  

  • 31. [Developmental manifestation in children with neurofibromatosis type 1].
    Cohen R; Shuper A
    Harefuah; 2010 Jan; 149(1):49-52, 61. PubMed ID: 20422842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutation spectrum of NF1 gene in Italian patients with neurofibromatosis type 1 using Ion Torrent PGM™ platform.
    Calì F; Chiavetta V; Ruggeri G; Piccione M; Selicorni A; Palazzo D; Bonsignore M; Cereda A; Elia M; Failla P; Figura MG; Fiumara A; Maitz S; Luana Mandarà GM; Mattina T; Ragalmuto A; Romano C; Ruggieri M; Salluzzo R; Saporoso A; Schepis C; Sorge G; Spanò M; Tortorella G; Romano V
    Eur J Med Genet; 2017 Feb; 60(2):93-99. PubMed ID: 27838393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Somatic NF1 mutation spectra in a family with neurofibromatosis type 1: toward a theory of genetic modifiers.
    Wiest V; Eisenbarth I; Schmegner C; Krone W; Assum G
    Hum Mutat; 2003 Dec; 22(6):423-7. PubMed ID: 14635100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype.
    Pasmant E; Sabbagh A; Hanna N; Masliah-Planchon J; Jolly E; Goussard P; Ballerini P; Cartault F; Barbarot S; Landman-Parker J; Soufir N; Parfait B; Vidaud M; Wolkenstein P; Vidaud D; France RN
    J Med Genet; 2009 Jul; 46(7):425-30. PubMed ID: 19366998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumorigenic properties of neurofibromin-deficient Schwann cells in culture and as syngrafts in Nf1 knockout mice.
    Wu M; Wallace MR; Muir D
    J Neurosci Res; 2005 Nov; 82(3):357-67. PubMed ID: 16180234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Gene therapy strategies and prospects for neurofibromatosis type 1].
    Zheng T; Zhu B; Wang Z; Li Q
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2024 Jan; 38(1):1-8. PubMed ID: 38225833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Germline and somatic NF1 gene mutation spectrum in NF1-associated malignant peripheral nerve sheath tumors (MPNSTs).
    Upadhyaya M; Kluwe L; Spurlock G; Monem B; Majounie E; Mantripragada K; Ruggieri M; Chuzhanova N; Evans DG; Ferner R; Thomas N; Guha A; Mautner V
    Hum Mutat; 2008 Jan; 29(1):74-82. PubMed ID: 17960768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mouse models of neurofibromatosis 1 and 2.
    Gutmann DH; Giovannini M
    Neoplasia; 2002; 4(4):279-90. PubMed ID: 12082543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurofibromin and NF1 gene analysis in composite pheochromocytoma and tumors associated with von Recklinghausen's disease.
    Kimura N; Watanabe T; Fukase M; Wakita A; Noshiro T; Kimura I
    Mod Pathol; 2002 Mar; 15(3):183-8. PubMed ID: 11904334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [From gene to disease; neurofibromatosis type 1].
    de Goede-Bolder A; Cnossen MH; Dooijes D; van den Ouweland AM; Niermeijer MF
    Ned Tijdschr Geneeskd; 2001 Sep; 145(36):1736-8. PubMed ID: 11572174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.